Co-Diagnostics Inc (NASDAQ:CODX)
| 1.09 Delayed Data As of Jan 17 |  +0.0299 / +2.82%Today’s Change | 0.69 Today|||52-Week Range 3.77 | +21.75% Year-to-Date |
Latest CODX News | Press Releases
No recent news for Co-Diagnostics Inc.
Today’s Trading
| Previous close | 1.06 |
| Today’s open | 1.07 |
| Day’s range | 1.07 - 1.10 |
| Volume | 92,070 |
| Average volume (3 months) | 103,183 |
| Market cap | $18.7M |
Data as of 3:57pm ET, 01/17/2020
Growth & Valuation
| Earnings growth (last year) | +20.25% |
| Earnings growth (this year) | +28.00% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +420.90% |
| P/E ratio | NM |
| Price/Sales | 466.09 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GENEGenetic Technologies... | -0.07 | -1.76% |
| DRIODarioHealth Corp | +0.77 | +10.27% |
| VXRTVaxart Inc | -0.02 | -3.91% |
| KMPHKemPharm Inc | +0.02 | +4.70% |
Data as of 4:00pm ET, 01/17/2020
Financials
| Next reporting date | February 26, 2020 |
| EPS forecast (this quarter) | -$0.09 |
| Annual revenue (last year) | $39.9K |
| Annual profit (last year) | -$6.3M |
| Net profit margin | -15,714.27% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Salt Lake City, Utah |
Forecasts
